Shanghai OPM Biosciences Co Ltd
SSE:688293
Intrinsic Value
Shanghai OPM Biosciences Co. Ltd. engages in the cell culture products and services. [ Read More ]
The intrinsic value of one Shanghai OPM Biosciences Co Ltd stock under the Base Case scenario is 35.74 CNY. Compared to the current market price of 37.55 CNY, Shanghai OPM Biosciences Co Ltd is Overvalued by 5%.
Valuation Backtest
Shanghai OPM Biosciences Co Ltd
Run backtest to discover the historical profit from buying and selling Shanghai OPM Biosciences Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Shanghai OPM Biosciences Co Ltd
| Current Assets | 1.7B |
| Cash & Short-Term Investments | 1.5B |
| Receivables | 106.2m |
| Other Current Assets | 58.7m |
| Non-Current Assets | 623.9m |
| Long-Term Investments | 278.2m |
| PP&E | 265.5m |
| Intangibles | 39.3m |
| Other Non-Current Assets | 40.9m |
| Current Liabilities | 52.5m |
| Accounts Payable | 26.8m |
| Accrued Liabilities | 9.3m |
| Short-Term Debt | 5.8m |
| Other Current Liabilities | 10.5m |
| Non-Current Liabilities | 58.4m |
| Long-Term Debt | 46.6m |
| Other Non-Current Liabilities | 11.7m |
Earnings Waterfall
Shanghai OPM Biosciences Co Ltd
|
Revenue
|
268.9m
CNY
|
|
Cost of Revenue
|
-104.8m
CNY
|
|
Gross Profit
|
164.1m
CNY
|
|
Operating Expenses
|
-100.9m
CNY
|
|
Operating Income
|
63.2m
CNY
|
|
Other Expenses
|
26.7m
CNY
|
|
Net Income
|
89.9m
CNY
|
Free Cash Flow Analysis
Shanghai OPM Biosciences Co Ltd
Profitability Score
Profitability Due Diligence
Shanghai OPM Biosciences Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Shanghai OPM Biosciences Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shanghai OPM Biosciences Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Shanghai OPM Biosciences Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shanghai OPM Biosciences Co Ltd
According to Wall Street analysts, the average 1-year price target for Shanghai OPM Biosciences Co Ltd is 52.57 CNY with a low forecast of 52.06 CNY and a high forecast of 54.12 CNY.
Shareholder Return
Price
Shanghai OPM Biosciences Co Ltd
| Average Annual Return | -12.87% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -68% |
| Market Capitalization | 4.3B CNY |
| Shares Outstanding | 114 772 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Shanghai OPM Biosciences Co. Ltd. engages in the cell culture products and services. The company is headquartered in Shanghai, Shanghai and currently employs 261 full-time employees. The company went IPO on 2022-09-02. The firm's cell culture medium products are widely used in the manufacturing of protein, antibiotics, vaccine, cell therapy products, gene therapy products, and other biological products. The firm's contract development and manufacturing organization (CDMO) service platform provides comprehensive services covering antibody engineering humanized screening, cell strain cultivation, process development, pilot scale production, and clinical-stage sample production. The firm conducts businesses both in the domestic market and overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Shanghai OPM Biosciences Co Ltd stock under the Base Case scenario is 35.74 CNY.
Compared to the current market price of 37.55 CNY, Shanghai OPM Biosciences Co Ltd is Overvalued by 5%.
You don't have any saved screeners yet
